About the journal
European Urology Oncology is a journal published by Elsevier BV in Netherlands. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,790 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 2588-9311
- Country
- Netherlands
- Access
- Not open access / not declared
- Declared publication charge
- 3,790 USD
- Declared peer-review model
- peer_review
- Official website
- https://www.journals.elsevier.com/european-urology-oncology
Index listings
- MEDLINE · 2019-01-01
- PUBMED · 2020-10-21
- Indexing
- MEDLINE · PUBMED
- APC
- 3,790 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 54 days received→accepted — computed from PubMed (n=100)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
1403
Last recorded publication year
2026
h-index
75
i10-index
599
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 94%
- ORCID iDs in current deposits
- 50%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity4
- Alternate titles
- EUO
- Source type
- journal
- NLM unique ID (PubMed)
- 101724904
- Society affiliations
- European Association of Urology
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Bladder and Urothelial Cancer Treatments
- Bladder and Urothelial Cancer Treatments
- Renal cell carcinoma treatment
- Renal cell carcinoma treatment
Show all subjects (50)
- Urinary and Genital Oncology Studies
- Urinary and Genital Oncology Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Urinary Bladder and Prostate Research
- Urinary Bladder and Prostate Research
- Advanced Radiotherapy Techniques
- Advanced Radiotherapy Techniques
- Esophageal Cancer Research and Treatment
- Esophageal Cancer Research and Treatment
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Radiopharmaceutical Chemistry and Applications
- Radiopharmaceutical Chemistry and Applications
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Urologic and reproductive health conditions
- Urologic and reproductive health conditions
- Ferroptosis and cancer prognosis
- Educational Robotics and Engineering
- Human auditory perception and evaluation
- MRI in cancer diagnosis
- Diverse Scientific and Economic Studies
- Educational Robotics and Engineering
- Diverse Scientific and Economic Studies
- Human auditory perception and evaluation
- Ferroptosis and cancer prognosis
- MRI in cancer diagnosis
- Renal and related cancers
- Renal and related cancers
- Cancer survivorship and care
- Cancer survivorship and care
- Urological Disorders and Treatments
- Urological Disorders and Treatments
- Radiomics and Machine Learning in Medical Imaging
- Radiomics and Machine Learning in Medical Imaging
- PARP inhibition in cancer therapy
- PARP inhibition in cancer therapy
- Urinary Tract Infections Management
- Urinary Tract Infections Management
- Multiple and Secondary Primary Cancers
- Multiple and Secondary Primary Cancers
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ